Acadia Pharmaceuticals Stock
Price
Target price
€19.28
€19.28
2.280%
0.425
2.280%
€25.68
06.06.25 / Tradegate
WKN: 603035 / Symbol: ACAD / Name: ACADIA Pharm / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Acadia Pharmaceuticals Stock
There is an upward development for Acadia Pharmaceuticals compared to yesterday, with an increase of €0.43 (2.280%).
With 25 Buy predictions and not a single Sell prediction Acadia Pharmaceuticals is an absolute favorite of our community.
As a result the target price of 25 € shows a positive potential of 29.67% compared to the current price of 19.28 € for Acadia Pharmaceuticals.
For the coming years our community has positive and negative things to say abot the Acadia Pharmaceuticals stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "EBIT growth" there were negative voices in the community.
Pros and Cons of Acadia Pharmaceuticals in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Acadia Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals | 2.280% | 1.527% | 46.227% | 37.469% | 19.938% | 20.244% | -52.277% |
| Ironwood Pharmaceuticals | -7.170% | -10.545% | -38.500% | -91.517% | -88.286% | -95.256% | -94.472% |
| Arrowhead Pharmaceuticals Inc. | 3.230% | 4.206% | 28.285% | -35.037% | -20.303% | -54.555% | -51.135% |
| Novocure Ltd | -1.370% | -14.583% | 0.174% | -29.371% | -50.618% | -80.703% | -76.153% |
Comments
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at JPMorgan Chase & Co. from $26.00 to $30.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ACAD provided by MarketBeat
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Show more
Ratings data for ACAD provided by MarketBeat
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft to $35.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ACAD provided by MarketBeat